OCUL
Ocular Therapeutix Inc Earnings
$9.64
Earnings Summary
Revenue | $13.25Mn |
Net Profits | $-64.65Mn |
Net Profit Margins | -487.95% |
Ocular Therapeutix Inc’s revenue fell -22.43% since last year same period to $13.25Mn in the Q4 2025. On a quarterly growth basis, Ocular Therapeutix Inc has generated -8.9% fall in its revenue since last 3-months.
Ocular Therapeutix Inc’s net profit fell -33.62% since last year same period to $-64.65Mn in the Q4 2025. On a quarterly growth basis, Ocular Therapeutix Inc has generated 6.86% jump in its net profits since last 3-months.
Ocular Therapeutix Inc’s net profit margin fell -72.26% since last year same period to -487.95% in the Q4 2025. On a quarterly growth basis, Ocular Therapeutix Inc has generated -2.23% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.35 |
EPS Estimate Current Year | -0.35 |
Ocular Therapeutix Inc’s earning per share (EPS) estimates for the current quarter stand at -0.35 - a -8.94% fall from last quarter’s estimates.
Ocular Therapeutix Inc’s earning per share (EPS) estimates for the current year stand at -0.35.
Key Ratios
Earning Per Share (EPS) | 0 |
Ocular Therapeutix Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Ocular Therapeutix Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-11 | -0.35 | 0 | 100% |
